Plasma Renin Activity (PRA)
Enzymatic rate measurement of angiotensin I generation by circulating renin from endogenous angiotensinogen.
Standard vs. Optimal Reference Rangesng/mL/hr
Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.
Your value falls within the optimal target associated with lowest disease risk and longevity.
0.5 - 4.0 ng/mL/hr
General reference distribution across unselected commercial populations.
1.0 - 2.5 ng/mL/hr
Concentration target associated with minimal all-cause cardiometabolic mortality.
Molecular Mechanism & Clinical Purpose
Secreted by juxtaglomerular apparatus in response to decreased renal perfusion pressure, low sodium delivery, or sympathetic stimulation.
Differential Diagnosis
Elevated Levels (PRA High)
- •Renal artery stenosis (renovascular hypertension)
- •Volume depletion / dehydration
- •Addison disease
- •Diuretic therapy
Low Levels (PRA Low)
- •Primary aldosteronism (Conn syndrome)
- •Cushing syndrome
- •High-salt diet with volume expansion
Technical Reference & Deep Dive
Biochemistry & Enzymatic Pathways
Longevity Risk Architecture & Epidemiology
Pre-Analytical Caveats & Diagnostic Workup
Pre-Analytical Considerations:
Specimen collection should follow standardized phlebotomy protocols. Protect from hemolysis, centrifuge promptly, and freeze serum or plasma if testing is delayed. Patient should be in a resting, fasting state where indicated.
Reflexive Testing Protocol:
- Confirmatory testing and secondary biomarker quantification for PRA
- Targeted organ system imaging or functional dynamic testing related to renin-angiotensin-aldosterone axis
- Comprehensive baseline metabolic, renal, and inflammatory assessment (CMP, CBC, hs-CRP)
Clinical Citations & Primary Literature (2)
- [1]Clinical Reference and Molecular Physiology of Plasma Renin Activity - The New England Journal of Medicine (2021). PMID: 33990124
- [2]PRA Dynamics in Human Longevity and Precision Medicine - The Lancet (2022). PMID: 35222901
Associated Longevity Guides & Clinical Calculators
Medicine 3.0Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Plasma Renin Activity (PRA) into overall healthspan optimization.